Reduced SLC25A21 expression led to decreased efflux of α-ketoglutarate from mitochondria, enhancing glutamine replenishment to support the metabolic demands of rapidly proliferating KRAS-mutant CRC cells [217]. Here, KRAS is linked to colorectal carcinoma.